Dealings By A Director Of The Company
STENPROP LIMITED
(Registered in Guernsey)
(Registration number 64865)
LSE share code: STP JSE share code: STP
ISIN: GG00BFWMR296
("Stenprop" or the "Company")
DEALINGS BY A DIRECTOR OF THE COMPANY
17 July 2020
Shareholders are advised of the following information relating to dealings in the Company's securities by a director:
Name of director: | James Beaumont |
Transaction date: | 16 July 2020 |
Class of securities: | Ordinary shares |
Number of securities sold: | 16,667 |
Price per security: | GBP 1.20 |
Deemed total value of the transaction: | GBP 20,000.40 |
Nature of transaction: Nature and extent of director's interest: | On-market sale Direct beneficial |
Clearance to deal: | Yes |
Name of director: | James Beaumont |
Transaction date: | 16 July 2020 |
Class of securities: | Ordinary shares |
Number of securities purchased: | 16,534 |
Price per security: | GBP 1.2096 |
Deemed total value of the transaction: | GBP 19,999.53 |
Nature of transaction: Nature and extent of director's interest: | On-market purchase through the director's stocks and shares ISA Direct beneficial |
Clearance to deal: | Yes |
For further information:
Stenprop Limited +44(0)20 3918 6600
Paul Arenson ([email protected])
Julian Carey ([email protected])
James Beaumont ([email protected])
Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000
Hugh Jonathan
Vicki Paine
Justin Bell
FTI Consulting +44(0)20 3727 1000
Richard Sunderland [email protected]
Richard Gotla
Indraneel Bose
Java Capital Trustees and Sponsors Proprietary Limited +27 (0)11 722 3050
(JSE Sponsor)
About Stenprop:
Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to stenprop.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.